Guedj, J., Dahari, H., Uprichard, S. L., & Perelson, A. S. (2013). The rapid viral decline with the HCV NS5A inhibitor daclatasvir reveals a dual mode of action and leads to a new HCV half-life estimate.
Chicago Style CitationGuedj, Jeremie, Harel Dahari, Susan L. Uprichard, and Alan S. Perelson. The Rapid Viral Decline With the HCV NS5A Inhibitor Daclatasvir Reveals a Dual Mode of Action and Leads to a New HCV Half-life Estimate. 2013.
MLA CitationGuedj, Jeremie, Harel Dahari, Susan L. Uprichard, and Alan S. Perelson. The Rapid Viral Decline With the HCV NS5A Inhibitor Daclatasvir Reveals a Dual Mode of Action and Leads to a New HCV Half-life Estimate. 2013.
Warning: These citations may not always be 100% accurate.